- Home
- Publications
- Publication Search
- Publication Details
Title
Amyloid-β Receptors: The Good, the Bad, and the Prion Protein
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 7, Pages 3174-3183
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-12-31
DOI
10.1074/jbc.r115.702704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer’s Disease
- (2015) Riddhi U. Bodani et al. ACS Chemical Neuroscience
- Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
- (2015) Kirsten L. Viola et al. ACTA NEUROPATHOLOGICA
- Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay
- (2015) Emmanuel Risse et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models
- (2015) Mikhail A. Kostylev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
- (2015) Zhen Zhao et al. NATURE NEUROSCIENCE
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly
- (2015) Takayuki Ohnishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration
- (2015) Peng Liu et al. Cell Reports
- Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
- (2015) Wen-Jie Du et al. Scientific Reports
- The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
- (2014) Kanchan Garai et al. BIOCHEMISTRY
- High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease
- (2014) Frank Dohler et al. BRAIN
- Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
- (2014) Deborah Doens et al. Journal of Neuroinflammation
- Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
- (2014) Yadong Huang et al. NEUROBIOLOGY OF DISEASE
- EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
- (2014) Lina M. Vargas et al. PLoS One
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
- (2014) Nicholas J. Izzo et al. PLoS One
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
- (2014) Nicholas J. Izzo et al. PLoS One
- Toward a unified therapeutics approach targeting putative amyloid- oligomer receptors
- (2014) C. R. Overk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer’s disease
- (2014) Amy K. Y. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
- (2014) Haakon B Nygaard et al. Alzheimers Research & Therapy
- Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
- (2014) William F Goure et al. Alzheimers Research & Therapy
- Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
- (2014) Natalia N. Nalivaeva et al. Frontiers in Aging Neuroscience
- A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-β and Regulates Its Clearance from the Mouse Brain
- (2013) Abhay P. Sagare et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1
- (2013) Jo V. Rushworth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer’s disease
- (2013) Tae-In Kam et al. JOURNAL OF CLINICAL INVESTIGATION
- Neuronal Clearance of Amyloid- by Endocytic Receptor LRP1
- (2013) T. Kanekiyo et al. JOURNAL OF NEUROSCIENCE
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- Promiscuous Alzheimer's Amyloid: Yet Another Partner
- (2013) I. Benilova et al. SCIENCE
- Human LilrB2 Is a -Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
- (2013) T. Kim et al. SCIENCE
- Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity
- (2013) Andrew J. Nicoll et al. Nature Communications
- Amyloid-β Oligomers are Sequestered by both Intracellular and Extracellular Chaperones
- (2012) Priyanka Narayan et al. BIOCHEMISTRY
- Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes
- (2012) Jacob M. Basak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid β (Aβ) Peptide Directly Activates Amylin-3 Receptor Subtype by Triggering Multiple Intracellular Signaling Pathways
- (2012) Wen Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular Prion Protein Participates in Amyloid-β Transcytosis across the Blood—Brain Barrier
- (2012) Thorsten Pflanzner et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-
- (2012) T. Kanekiyo et al. JOURNAL OF NEUROSCIENCE
- Soluble A Promotes Wild-Type Tau Pathology In Vivo
- (2012) M. A. Chabrier et al. JOURNAL OF NEUROSCIENCE
- The Complex PrPc-Fyn Couples Human Oligomeric A with Pathological Tau Changes in Alzheimer's Disease
- (2012) M. Larson et al. JOURNAL OF NEUROSCIENCE
- Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
- (2012) R Killick et al. MOLECULAR PSYCHIATRY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
- (2012) Ji Won Um et al. NATURE NEUROSCIENCE
- Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood A clearance in a mouse model of -amyloidosis
- (2012) J. M. Castellano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Out-of-register -sheets suggest a pathway to toxic amyloid aggregates
- (2012) C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atomic View of a Toxic Amyloid Small Oligomer
- (2012) Arthur Laganowsky et al. SCIENCE
- Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
- (2011) H. Rheinallt Parri et al. BIOCHEMICAL PHARMACOLOGY
- The Synaptic Protein Neuroligin-1 Interacts with the Amyloid β-Peptide. Is There a Role in Alzheimer’s Disease?
- (2011) Margarita C. Dinamarca et al. BIOCHEMISTRY
- Single-channel Ca2+imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology
- (2011) Angelo Demuro et al. JOURNAL OF CELL BIOLOGY
- Alzheimer's Disease Brain-Derived Amyloid- -Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
- (2011) A. E. Barry et al. JOURNAL OF NEUROSCIENCE
- Soluble A Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
- (2011) S. Li et al. JOURNAL OF NEUROSCIENCE
- Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid- Uptake
- (2011) T. Kanekiyo et al. JOURNAL OF NEUROSCIENCE
- The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
- (2011) Sergio T. Ferreira et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices
- (2011) Gerhard Rammes et al. NEUROPHARMACOLOGY
- Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites
- (2011) Darragh B. Freir et al. Nature Communications
- Signalosomes in the brain: relevance in the development of certain neuropathologies such as Alzheimer’s disease
- (2011) Raquel Marin Frontiers in Physiology
- Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
- (2010) Erika Chung et al. BMC NEUROSCIENCE
- β-Amyloid activates presynaptic α7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts
- (2010) Ghous M. Khan et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Binding of amyloid β peptide to β2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity
- (2010) Dayong Wang et al. FASEB JOURNAL
- Cellular roles of the prion protein in association with reggie/flotillin microdomains
- (2010) Gonzalo et al. Frontiers in Bioscience-Landmark
- Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers
- (2010) Ali Reza A. Ladiwala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers
- (2010) Shugui Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells
- (2010) Lars-Ove Brandenburg et al. JOURNAL OF NEUROCHEMISTRY
- Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
- (2010) D. A. Gimbel et al. JOURNAL OF NEUROSCIENCE
- Microglial Receptor for Advanced Glycation End Product-Dependent Signal Pathway Drives -Amyloid-Induced Synaptic Depression and Long-Term Depression Impairment in Entorhinal Cortex
- (2010) N. Origlia et al. JOURNAL OF NEUROSCIENCE
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
- (2010) Moustapha Cissé et al. NATURE
- Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
- (2010) Marianne Renner et al. NEURON
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains
- (2009) Akihiko Noguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
- (2009) Wei-Qin Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
- (2009) Cameron R Stewart et al. NATURE IMMUNOLOGY
- Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
- (2009) Jennifer L. Tomic et al. NEUROBIOLOGY OF DISEASE
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
- (2009) Fernanda G. De Felice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
- (2009) M. Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RAGE-mediated signaling contributes to intraneuronal transport of amyloid- and neuronal dysfunction
- (2009) K. Takuma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glypican-1 Mediates Both Prion Protein Lipid Raft Association and Disease Isoform Formation
- (2009) David R. Taylor et al. PLoS Pathogens
- In situAbetapores in AD brain are cylindrical assembly of Abetaprotofilaments
- (2008) Sadayuki Inoue AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Structural Classification of Toxic Amyloid Oligomers
- (2008) Charles G. Glabe JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling
- (2008) Margaret H. Magdesian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid Oligomers (A 1-42 Globulomer) Suppress Spontaneous Synaptic Activity by Inhibition of P/Q-Type Calcium Currents
- (2008) V. Nimmrich et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Physiology of the Prion Protein
- (2008) Rafael Linden et al. PHYSIOLOGICAL REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started